CAPRICOR THERAPEUTICS, INC. (CAPR) Return on equity 2017–2025
CAPRICOR THERAPEUTICS, INC. (CAPR) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-34.4%FY2025 · since FY2017: 21.7% → -34.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -34.4% | -6.5 pp |
| FY2024 | -27.8% | +70.8 pp |
| FY2023 | -98.6% | +147.6 pp |
| FY2022 | -246.2% | -182.4 pp |
| FY2021 | -63.8% | -15.4 pp |
| FY2020 | -48.4% | +63.3 pp |
| FY2019 | -111.7% | +217.4 pp |
| FY2018 | -329.1% | -350.8 pp |
| FY2017 | 21.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice